Abstract 413P
Background
To study of immunohistochemical markers of proliferation and apoptosis are important prognostic indicators for predicting the clinical course of tumours and the development of therapeutic tactics.
Methods
The p53 suppressor gene, the bcl-2 oncogene and the Ki-67 antigen are responsible for DNA repair, cell division and apoptosis. In all patients, tumour material was obtained using biopsies and operations. In tumour tissue samples fixed by neutral formalin with standard wiring and embedded in paraffin, tumour markers of apoptosis and proliferation were determined - p53, bcl-2, Ki – 67. A positive result was the presence of specific brown staining of the nuclei in the detection of the Ki-67 antigen and the p53 gene suppressor and the cytoplasm in the detection of the expression of bCl-2.
Results
Cases where the nucleus or cytoplasm was not stained by reaction with antibodies to p53, Ki-67 and bcl-2 or the number of positive cells was less than 10%, the reaction was considered negative (0). Weak (1+) reaction was considered when staining 10-30% of cells; medium reaction (2+) - when staining 30-50% of cells; strong reaction (3+) - intense staining from 70 or more cells. We carried out a comparative assessment of the effectiveness of treatment of patients depending on the type of therapy and the phenotype of tumour cells. Among patients who received systemic chemotherapy, the full effect was observed in 13% of patients. With negative and weakly positive reactions to the mutant p53 gene and Ki 67 among them was 70.6%, and with moderate and strong expression of bcl-2 (80%). Patients with a phenotype of tumour cells with a negative or weakly positive IHC response to the mutant p53 gene (58.5% of patients), weakly positive expression of Ki 67 (70.6% of patients), and high expression of bcl-2 (46.4 % of patients). In 37.4% of patients from this group, the effect of therapy was negative, most of them had tumour cells with high expression of the mutant p53 and Ki 67 gene, and no expression of bcl-2.
Conclusions
It was established that with positive expression of p53 + Ki-67 + and negative bcl-2 parameters, patients had an unfavourable prognosis.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Ronc.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
174P - Progression of computer aided diagnosis on gastric cancer
Presenter: Yingyan Yu
Session: Poster display session
Resources:
Abstract
175P - Hypermethylation of the PCDHB15 promoter predicts the prognosis in gastric cancer
Presenter: Yu-ting Lee
Session: Poster display session
Resources:
Abstract
176P - DCLK1 promotes tumour invasion and metastasis through epithelial-mesenchymal transition and the MEK/ERK pathway in esophageal squamous cell carcinoma
Presenter: Jiannan Yao
Session: Poster display session
Resources:
Abstract
177P - Comparison of nab-paclitaxel plus ramcirumab and paclitaxel plus ramcirumab in patients with pretreated metastatic gastric cancer
Presenter: Yosuke Horita
Session: Poster display session
Resources:
Abstract
178P - Chief cell in stomach have stem cell activity and potential to develop gastric cancer
Presenter: Akihiro Yamamura
Session: Poster display session
Resources:
Abstract
179P - Postoperative Adjuvant transarterial chemoembolization versus surgery alone for resected hepatocellular carcinoma: A propensity-score matching study
Presenter: Mingyu Chen
Session: Poster display session
Resources:
Abstract
180P - LHPP inhibit the cell proliferation and EMT via the TGFβ/SMAD3 signaling pathway in iCCA
Presenter: Dan Wang
Session: Poster display session
Resources:
Abstract
181P - The emerging role of third-line gemcitabine plus nab-paclitaxel in advanced pancreatic adenocarcinoma
Presenter: Andrew Dean
Session: Poster display session
Resources:
Abstract
182P - Durable response to second-line m-FOLFIRINOX for advanced pancreatic adenocarcinoma in patients with performance status of two or less
Presenter: Adarsh Das
Session: Poster display session
Resources:
Abstract
183P - Epidemiologic profile of gastric cancer in East Azerbaijan, Iran: 2 years population-based cancer registry results
Presenter: Pooneh Jabbaripour
Session: Poster display session
Resources:
Abstract